Trademark Overview
On Wednesday, December 11, 2024, a trademark application was filed for TPDC with the United States Patent and Trademark Office. The USPTO has given the TPDC trademark a serial number of 79420197. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 27, 2025. This trademark is owned by ClichemBIO, Inc.. The TPDC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating diabetes; cardiovascular pharmaceutical preparations; compounds for treating cancer; pharmaceutical preparations for treating inflammatory diseases; biological preparations for medical or veterinary purposes; pharmaceutical products, namely, for the prevention and treatment of cancer; pharmaceutical products, namely, for the treatment of inflammatory diseases; pharmaceutical preparations for diagnosis of cancer; pharmaceutical preparations for diagnosis of inflammatory diseases; therapeutic drugs and agents; anti-cancer preparations